Stockreport

TFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)

TFF Pharmaceuticals, Inc.  (TFFP) 
PDF First clinical study in healthy subjects of a direct-to-lung, Thin Film Freezing (TFF) dry-powder formulationInvasive Pulmonary Aspergillosis is a severe fungal pulmonar [Read more]